4th Edition

Husband & Reznek's Imaging in Oncology

Edited By Anju Sahdev, Sarah J. Vinnicombe Copyright 2020
    849 Pages 207 Color & 1825 B/W Illustrations
    by CRC Press

    849 Pages 207 Color & 1825 B/W Illustrations
    by CRC Press

    This comprehensive reference provides an overview of the general principles of cancer staging, as well as specific discussions of each tumour type across the body, including lymphoma and haematological malignancies. For each tumour, the pattern of disease involvement and disease spread are emphasized, the state-of-the-art imaging features surveyed, and the latest tumour staging and methods to assess treatment response are addressed. Separate sections discuss metastatic disease and the effects of treatment on normal and diseased tissues. The final section of the book highlights emerging functional and molecular imaging techniques to evaluate the different biological hallmarks of cancer.

    Contributors

    PART I: PRIMARY TUMOUR EVALUATION AND STAGING

    1. Tumours of the oral cavity and pharynx

    Kunwar S. S. Bhatia, Ann D. King, and Robert Hermans

    2. Paranasal sinus and nasal cavity neoplasms

    Sofia Otero and Tim Beale

    3. Laryngeal tumours

    Philip Touska, Steve Connor, and Robert Hermans

    4. Thyroid cancer

    Gitta Madani and Polly S. Richards

    5. Mediastinal tumours

    Jonathan Goldin

    6. Lung cancer

    Stephen M. Ellis and Zelena Aziz

    7. Pleural tumours

    Bhavin Rawal and Sujal R. Desai

    8. Breast cancer

    Sarah J. Vinnicombe and Alexandra Athanasiou

    9. Oesophageal cancer

    Nyree Griffin, Jason Dunn, and Lee Alexander Grant

    10. Gastric cancer

    Jacob S. Ecanow and Richard M. Gore

    11. Primary tumours of the liver and biliary tract

    Hero K. Hussain and Mohammad Abu Shattal

    12. Pancreatic malignancy

    Giovanni Morana, Alex Faccinetto, and Michele Fusaro

    13. Renal cancer

    Conrad von Stempel, Lee Alexander Grant, Miles Walkden, and Navin Ramachandran

    14. Primary adrenal malignancy

    Ayshea Hameeduddin, Anju Sahdev, and Rodney H. Reznek

    15. Primary retroperitoneal tumours

    Isaac R. Francis, Richard H. Cohan, and William R. Burns

    16. Bladder cancer

    Anju Sahdev

    17. Prostate cancer

    Jurgen J. Fütterer, Fillip Kossov, and Henkjan Huisman

    18. Testicular cancer

    Edward Nganga and Aslam Sohaib

    19. Ovarian cancer

    Stephanie Nougaret, Helen Addley, Evis Sala, and Anju Sahdev

    20. Cervical and uterine tumours

    Rosemarie Forstner and Andrea Rockall

    21. Colorectal cancer

    Svetlana Balyasnikova and Gina Brown

    22. Primary bone tumours

    Jennifer N. Murphy, Steven L. J. James, Murali Sundaram, and A. Mark Davies

    23. Soft tissue sarcomas

    Christina Messiou, Dirk Strauss, and Eleanor Moskovic

    24. Neuroendocrine tumours

    Sairah R. Khan, Kathryn L. Wallitt, Adil Al-Nahhas, and Tara D. Barwick

    PART II: HAEMATOLOGICAL MALIGNANCY AND IMMUNE RELATED MALIGNANCY

    25. Lymphoma

    Sarah J. Vinnicombe and Rodney J. Hicks

    26. Multiple myeloma

    Conor D. Collins

    PART III: METASTASES

    27. Brain metastases

    Anant Subramanian Krishnan and Jane Evanson

    28. Lymph node metastases

    Dow-Mu Koh and Gigin Lin

    29. Lung and pleural metastases

    Matthew Gilman and Amita Sharma

    30. Bone metastases

    Rupert Berkeley, Muaaze Ahmad, and Rikin Hargunani

    31. Liver and spleen metastases

    Wolfgang Schima, Helmut Kopf, and Claus Kölblinger

    32. Adrenal metastases

    Khawaja Shahabuddin, Rodney H. Reznek, and Anju Sahdev

    33. Peritoneal metastases

    Louisa Firmin and Zahir Amin

    PART IV: DISEASE RESPONSE AND TREATMENT

    34. Assessment of response to treatment

    Lawrence H. Schwartz, Binsheng Zhao, and Marius E. Mayerhoefer

    35. Tumour-specific disease response criteria

    Katja De Paepe and Nina Tunariu

    36. Immunotherapy response

    Bernhard Gebauer

    PART V: EFFECTS ON NORMAL TISSUE AND COMPLICATIONS OF TREATMENTS

    37. Oncological effects on the central nervous system

    Jane Evanson

    38. Effects of treatment on the thorax

    Dhakshina Moorthy Ganeshan, Herman I. Libshitz, and Revathy B. Iyer

    39. Effects of treatment on the abdomen and pelvis

    Rohit Kochhar and Philip Borg

    40. Effects of treatment on bone and bone marrow

    Lia A. Moulopoulos and Vassilis Koutoulidis

    PART VI: FUNCTIONAL AND MOLECULAR IMAGING

    41. PET-CT: Principles and clinical applications

    Mario Jreige, Marie Nicod-Lalonde, John O. Prior, and Niklaus Schaefer

    42. Functional imaging and emerging techniques in MRI

    Roberto García-Figueiras, Anwar Padhani, and Sandra Baleato-González

    43. Functional imaging and emerging techniques in CT

    Vicky Goh, Christian Kelly-Morland, and Davide Prezzi

    44. Non-FDG radionuclide imaging and targeted therapies

    Luigi Aloj and Ferdia A. Gallagher

    Index

    Biography

    Anju Sahdev is the director of research for Clinical Support Services (CSS) and leads the Research Team within the Department of Imaging. Her many research achievements include multiple awards and prizes from a number of international and national organisations for her work involving MRI and endocrine/GU/gynaecological radiology including RSNA, UKRC, ECR and The British Medical Journal. She is also the reporting radiologist on MEDAL, METRO BIBF, METERO, ICON8, PANDA, PISARRO, LOGS, INTERLACE, ARIEL 3 and NEPTUNE.                                                                                         

    Sarah Vinnicombe is a Clinical Senior Lecturer in Cancer Imaging and Consultant. Radiologist at Ninewells Hospital Medical School, University of Dundee. She was the British Society of Breast Radiologists' Visiting Professor in 2013 and has been elected Fellow of the International Cancer Imaging Society.